Business Practice

History was made this past month as China's National Medical Products Administration approved the country's first CAR T-cell therapy: Yescarta.

How is AI shaping the future of pharma?

How is the OTC industry rising to pharma's biggest challenges?

The lack of female representation in clinical trials impairs the very foundation that the development of safe and effective medicines is built upon.

Experts from the BIA got together to discuss how the UK’s biotechnology industry can plug the UK’s worrying skills gap.

Are there learnings from the COVID-19 pandemic that could be applied to the development and commercialization of advanced therapies?

How can advocacy groups help improve the clinical trials landscape?

Does pharma have the right mindset when it comes to adopting and implementing AI more widely?

What was described by a University of California professor as gene therapy's "single most remarkable achievement?"

Is waiving patents for COVID-19 vaccines the right step forward?